Provided by Tiger Fintech (Singapore) Pte. Ltd.

Darling Ingredients

32.34
+0.14000.43%
Volume:1.37M
Turnover:43.58M
Market Cap:5.11B
PE:30.27
High:32.35
Open:32.15
Low:30.88
Close:32.20
Loading ...

Darling Ingredients Inc expected to post earnings of 35 cents a share - Earnings Preview

Reuters
·
23 Apr

Exploring Analyst Estimates for Darling (DAR) Q1 Earnings, Beyond Revenue and EPS

Zacks
·
21 Apr

Analysts Estimate Darling Ingredients (DAR) to Report a Decline in Earnings: What to Look Out for

Zacks
·
17 Apr

Darling Ingredients Is Maintained at Outperform by Baird

Dow Jones
·
15 Apr

Is There Now An Opportunity In Darling Ingredients Inc. (NYSE:DAR)?

Simply Wall St.
·
15 Apr

Darling Ingredients price target lowered to $41 from $51 at Baird

TIPRANKS
·
15 Apr

Robert W. Baird Sticks to Their Buy Rating for Darling Ingredients (DAR)

TIPRANKS
·
15 Apr

Press Release: Darling Ingredients Inc. to Release First Quarter 2025 Financial Results

Dow Jones
·
15 Apr

New Strong Sell Stocks for April 9th

Zacks
·
09 Apr

Darling Ingredients Doesn't See Big Impact From Tariffs -- Market Talk

Dow Jones
·
07 Apr

Darling Ingredients Says Exposure to Tariff-Impacted Exports Minimal

MT Newswires Live
·
07 Apr

Darling Ingredients has ‘minimal exposure’ to exports impacted by tariffs

TIPRANKS
·
07 Apr

BRIEF-Darling Ingredients Issues Statement On Tariffs

Reuters
·
07 Apr

Darling Ingredients Inc - Current Tariff Developments Not Material to Business

THOMSON REUTERS
·
07 Apr

Darling Ingredients Inc - Minimal Exposure to Exports Impacted by Current Tariffs

THOMSON REUTERS
·
07 Apr

Darling Ingredients Issues Statement on Tariffs

THOMSON REUTERS
·
07 Apr

Darling Ingredients Inc : TD Cowen Cuts Target Price to $37 From $43

THOMSON REUTERS
·
04 Apr

Is Darling Ingredients Inc.'s (NYSE:DAR) Recent Price Movement Underpinned By Its Weak Fundamentals?

Simply Wall St.
·
28 Mar

Elevation Oncology to Present Preclinical Data for EO-1022 at the American Association for Cancer Research (AACR) Annual Meeting 2025

PR Newswire
·
26 Mar

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.

GlobeNewswire
·
22 Mar